{"id":"W4286447573","doi":"10.1016/j.ejca.2022.06.045","title":"Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials","year":2022,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Avid Radiopharmaceuticals; Astellas Pharma; CRIS Cancer Foundation; Sociedad Española de Oncología Médica; Mirati Therapeutics; Genentech; Symphogen; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; GlaxoSmithKline","keywords":"Biomarker; Medicine; Clinical trial; Pharmacodynamics; Oncology; Internal medicine; Imaging biomarker; Drug development; Biomarker discovery; Drug; Pharmacokinetics; Pharmacology; Radiology; Magnetic resonance imaging","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.341105,0.001039511,0.004125867,0.005274064,0.0006664828,0.008874371,0.001800647,0.003310703,0.004744396],"category_scores_gemma":[0.5031633,0.0007517099,0.00509614,0.007061599,0.001922727,0.0074951,0.002496297,0.003652485,0.0009739701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003934972,"about_ca_system_score_gemma":0.005174013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00027312,"about_ca_topic_score_gemma":0.0005140662,"domain_scores_codex":[0.5775922,0.3259962,0.05928395,0.008303274,0.02705376,0.001770672],"domain_scores_gemma":[0.202557,0.6288492,0.1176604,0.01020314,0.03761531,0.003115019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0523428,0.0005194118,0.05792251,0.09594446,0.01498523,0.0003340561,0.000895413,0.003793528,0.001888489,0.006306991,0.02008278,0.7449842],"study_design_scores_gemma":[0.03599305,0.05281688,0.1810533,0.188426,0.05425632,0.003084062,0.001318259,0.009227448,0.01086328,0.02512112,0.4372465,0.0005937091],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04039677,0.9078677,0.00850499,0.02027817,0.003033375,0.003348242,0.002805004,0.0001322649,0.01363357],"genre_scores_gemma":[0.6805372,0.2465086,0.03032821,0.02109493,0.007173335,0.007944539,0.004430308,0.0003271638,0.001655731],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.341105,"threshold_uncertainty_score":0.8125348,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4504025401027008,"score_gpt":0.6640550157850593,"score_spread":0.2136524756823586,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}